FDA Reports 51 Deaths Of Attention Drug Patients; Includes Shire Pharmaceuticals Group plc’s Adderall And Novartis Pharma AG’s Ritalin

WASHINGTON, Feb 8 (Reuters) - Deaths of 51 U.S. patients who took widely prescribed drugs to treat attention deficit disorder prompted regulators to start watching for heart attacks, high blood pressure and other problems in 2004, a report released on Wednesday said.